Journal of Innovations in Pharmaceutical and Biological Sciences
Read the article
Visual summary · Journal of Innovations in Pharmaceutical and Biological Sciences

Potential of biological macromolecules as innovative approach for diabetes management: A review

Dr. Sushanta Kumar Das, Dibyendu Shil, Amit Samanta, Subham Roy, Chayanika Goswami

The question

What could biological macromolecules offer in the management of diabetes?

  • Diabetes mellitus is a complex and widespread disorder of metabolism and a considerable challenge to health worldwide.
  • Insulin therapy stays a cornerstone of care, but resistance to it and the complications that follow make other strategies necessary, in the authors' account.

What was done

Sixclasses of macromolecule examined
Enzymesgrowth factors, antibodies and more
Stem cellsamong the therapies reviewed
  • This is a review of what biological macromolecules might do in the management of diabetes.
  • It takes in enzymes and growth factors, antibodies and polysaccharides, and also nucleic acids and stem cells, with the parts they play in the disease.
  • It also looks at what recent work in protein engineering, targeted delivery of drugs and regenerative medicine has made possible.

Key findings

Finding 1 of 4
Six classes
of biological macromolecule are examined for use in diabetes

Stem cells, nucleic acids, polysaccharides, antibodies, growth factors and enzymes are each examined, with the several parts they play in the disease.

Finding 2 of 4
Glucose control
protection of beta cells and damping of oxidative stress among the mechanisms described

The macromolecules are described as working through fine control of glucose balance, protection of the beta cells that make insulin, and a damping of oxidative stress, which the authors call a key driver of complications.

Finding 3 of 4
Protein engineering
targeted delivery and regenerative medicine opened the way

Recent advances in protein engineering, in targeted systems for delivering drugs and in regenerative medicine have opened the way to macromolecular therapeutics that are specific, potent and long-lasting.

Finding 4 of 4
More research
and clinical trials are called for

The authors stress that continued research and clinical trials are critically needed before such findings can become treatments centred on the patient.

Why it matters

  • The authors hold that the metabolic pathways these molecules influence must be understood deeply, if their effect is to be improved and side effects kept small.
  • They present the field as one of promise for the care of diabetes, not as a set of results already in hand.

How to cite

Dr. Sushanta Kumar Das, Dibyendu Shil, Amit Samanta, Subham Roy, Chayanika Goswami. Potential of biological macromolecules as innovative approach for diabetes management: A review. Journal of Innovations in Pharmaceutical and Biological Sciences. 2025;12(01):21-39. https://doi.org/10.56511/jipbs.2025.12104

Open the article